Search results
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 5 days agoThe antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...
Women denied ‘wonder drug’ that could double terminal breast cancer life expectancy
Daily Telegraph· 3 days agoWomen with HER2-low or ultra-low breast cancer who took Enhertu lived without their cancer growing...
ASCO 2024: What's New in Breast Cancer Research?
Medscape· 20 hours agoDrs Alexandra Thomas and Virginia Kaklamani discuss highlights in breast cancer research from the ASCO 2024 Annual Meeting.
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC Universal via AOL· 5 days agoBy attaching a chemotherapy drug to an antibody, doctors are able to deliver more potentcancer...
Cancer patients often do better with less intensive treatment, new research finds
Medical Xpress· 4 days agoIt's part of a long-term trend toward studying whether doing less—less surgery, less chemotherapy or...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 1 day agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Breast cancer drug denied on NHS gives incurable women 'precious extra time'
Daily Express· 3 days agoA wonder drug denied to thousands of women in England with incurable breast cancer could keep their...
Astra's Enhertu breast cancer trial shows 'unprecedented' results
Reuters via Yahoo News· 4 days agoThe findings, presented in Chicago at the annual meeting of the American Society of Clinical...
With new Enhertu data, an ADC could overtake chemo in breast cancer
BioPharma Dive via Yahoo Finance· 5 days agoThe findings suggest Enhertu, a type of medicine called an antibody-drug conjugate, should be used...
Breakthroughs in Breast Cancer: Susan G. Komen(R) | Newswise
Newswise· 20 hours agoScholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization, showcased cutting-edge breast